Afamac 30 Tablet
Marketer
Admac Pharma Ltd
Salt Composition
Afatinib dimaleate (30mg)
Overview Afamac 30 Tablet
Afamatin 30mg tablets are indicated for treating non-small cell lung cancer in adults with specific epidermal growth factor receptor (EGFR) gene mutations. Optimal absorption requires administration on an empty stomach, consistently at the same time daily. Dosage and frequency are determined by your physician based on your individual needs and may vary. Strict adherence to your prescribed regimen is crucial; incorrect usage or overdose can lead to severe adverse effects. Therapeutic benefits may not be apparent for several weeks or months; discontinue only upon your doctor's instruction. Common side effects include nausea, diarrhea (which may be severe and require medical management), rash, and dry skin. Regular blood tests may be recommended. Photosensitivity is possible; sunscreen and protective clothing are advised when exposed to sunlight. Report eye pain, redness, or dryness to your physician immediately. Prior to commencing treatment, disclose any respiratory issues, hepatic or renal impairment, or concurrent use of anti-infective medications. Potential drug interactions exist; inform your healthcare provider of all medications you are taking. This medication is contraindicated during pregnancy and breastfeeding; women of childbearing age should utilize effective contraception during treatment.
Uses of Afamac 30 Tablet
Lung cancer (excluding small cell types)
Major Benefits of Afamac 30 Tablet:
Consume this medication precisely as prescribed by your physician, adhering to both the dosage and treatment length. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Afamac 30 Tablet should be administered on an empty stomach.
Common Side effects of Afamac 30 Tablet:
- Diarrhea
- Rash
- Dry skin
- Nausea
- Vomiting
- Loss of appetite
- Itching
- Stomatitis (Inflammation of the mouth)
- Nail disorder
How to use Afamac 30 Tablet:
Consume this medication precisely as your physician directs, adhering to the prescribed dosage and treatment period. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Afamac 30 Tablet should be administered on an empty stomach.
How Afamac 30 Tablet works:
Afamac 30 Tablet is an anticancer drug that targets and blocks specific enzyme receptors (EGFR, HER2, and HER4) crucial for cancer cell proliferation. This inhibition disrupts the cellular signaling pathways that drive cancer growth, effectively slowing or halting its progression.
SAFETY ADVICE
AlcoholSAFE
There are no known adverse interactions between Afamac 30 Tablet and alcohol consumption.
PregnancyCONSULT YOUR DOCTOR
Using Afamac 30 Tablet during pregnancy poses a confirmed risk to the fetus. Prescribing it may be considered only in exceptional, life-threatening circumstances where potential benefits outweigh the known hazards. Physician consultation is essential.
Breast feedingCONSULT YOUR DOCTOR
Use of Afamac 30 Tablet while breastfeeding is likely inadvisable. Preliminary human data indicate potential transfer to breast milk, posing a possible risk to the infant.
DrivingCONSULT YOUR DOCTOR
Afamac 30 Tablet's effect on driving ability is undetermined. Refrain from driving if you experience symptoms impairing concentration or reaction time.
KidneySAFE IF PRESCRIBED
The use of Afamac 30 Tablet in individuals with kidney disease is likely safe. Preliminary evidence indicates dose modification may not be necessary. However, physician consultation is recommended.
LiverSAFE IF PRESCRIBED
Use of Afamac 30 Tablet in patients with liver disease appears to pose minimal risk. Existing evidence indicates dose modification may be unnecessary; however, physician consultation is recommended.
What if you forget to take Afamac 30 Tablet :
Omit any missed Afamac 30 Tablet dose and resume your regular medication regimen; avoid taking a double dose.
Facts to Know About Afamac 30 Tablet
| Label | Value |
|---|---|
| Chemical Type | Quinazoline-Butenamide Hybrid |
| Developing Habits | No. |
| Treatment Category | Cancer Medications |
| Action Category | Kinase inhibitors targeting tyrosine |
3,018 People bought this recently
